Current influencing factors for prostate cancer ICPI include TMB, microsatellite instability/mismatch repair (MSI/MMR), and cyclin-dependent kinase 12 gene, but more biomarkers affecting ICPI are still being studied and explored. Here, CDK12 is linked to prostate carcinoma.